JGC
BDSI

J. Goldman & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

J. Goldman & Co’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-115,550
Closed -$438K – 388
2020
Q1 		$438K Buy
115,550
+37,593
+48% +$185K 0.05% 181
2019
Q4 		$493K Sell
77,957
-422,065
-84% -$2.48M 0.04% 217
2019
Q3 		$2.1M Buy
500,022
+300,022
+150% +$1.28M 0.16% 154
2019
Q2 		$930K Buy
+200,000
New +$931K 0.06% 203
2017
Q4 		– Sell
-135,000
Closed -$398K – 500
2017
Q3 		$398K Buy
+135,000
New +$411K 0.02% 278

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

J. Goldman & Co's BDSI Position: Q2 2020 in Review

J. Goldman & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 115,550 shares — an estimated $438K sold.

J. Goldman & Co first reported a position in BDSI in Q3 2017 and held it in 5 quarters. The position peaked at $2.1M in Q3 2019. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • J. Goldman & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
  • J. Goldman & Co sold 115,550 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $438K.
  • J. Goldman & Co first reported a position in BioDelivery Sciences International, Inc. in Q3 2017 and held it in 5 quarters.
  • J. Goldman & Co's BioDelivery Sciences International, Inc. position peaked at $2.1M in Q3 2019.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.